IA
GILD icon

Integrity Alliance’s Gilead Sciences GILD Stock Holding History

Integrity Alliance’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$586K Buy
4,635
+716
+18% +$94.3K 0.02% 469
2026
Q1 		$546K Sell
3,919
-176
-4% -$24.6K 0.02% 421
2025
Q4 		$503K Buy
+4,095
New +$498K 0.02% 460
2025
Q2 		– Sell
-1,872
Closed -$210K – 550
2025
Q1 		$210K Buy
+1,872
New +$193K 0.01% 579

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Integrity Alliance's GILD Position: Q2 2026 in Review

Integrity Alliance increased its Gilead Sciences (GILD) stake by 18% in Q2 2026, buying an estimated $94.3K and bringing the position to 4,635 shares worth $586K. The position accounts for 0.02% of the portfolio, ranked #469.

Integrity Alliance first reported a position in GILD in Q1 2025 and has held it in 4 quarters since. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Integrity Alliance held 4,635 shares of Gilead Sciences worth $586K as of Q2 2026.
  • Integrity Alliance bought 716 Gilead Sciences shares in Q2 2026, an estimated $94.3K.
  • Gilead Sciences made up 0.02% of Integrity Alliance's portfolio in Q2 2026, its #469 holding.
  • Integrity Alliance first reported a position in Gilead Sciences in Q1 2025 and has held it in 4 quarters since.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Integrity Alliance's 13F filing for Q2 2026, filed 31 Jul 2026.